SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-005820
Filing Date
2020-04-03
Accepted
2020-04-03 20:40:38
Documents
2
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1616
2 ex24.htm EX-24 8396
  Complete submission text file 0001493152-20-005820.txt   11607
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Issuer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC 100 OVERLOOK CENTER PRINCETON NJ 08540
Business Address
Cross John Harry III (Reporting) CIK: 0001806763 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35570 | Film No.: 20775549